{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T15:27:34Z","timestamp":1759073254914},"reference-count":38,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007359","name":"\u201cFondazione Banco di Sardegna\u201d","doi-asserted-by":"publisher","award":["2013-1522"],"award-info":[{"award-number":["2013-1522"]}],"id":[{"id":"10.13039\/100007359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","schres-journal.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.schres.2015.04.006","type":"journal-article","created":{"date-parts":[[2015,5,3]],"date-time":"2015-05-03T00:56:51Z","timestamp":1430614611000},"page":"181-187","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["On the use of the Positive and Negative Syndrome Scale in randomized clinical trials"],"prefix":"10.1016","volume":"165","author":[{"given":"Eraldo","family":"Nicotra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"Casu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Piras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Marchese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.schres.2015.04.006_bb0010","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1982.04290070025006","article-title":"Negative vs positive schizophrenia. Definition and validation","volume":"39","author":"Andreasen","year":"1982","journal-title":"Arch. Gen. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2015.04.006_bb0005","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/appi.ajp.162.3.441","article-title":"Remission in schizophrenia: proposed criteria and rationale for consensus","volume":"162","author":"Andreasen","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2015.04.006_bb0015","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1192\/S0007125000071919","article-title":"Positive and negative schizophrenic symptoms and the role of dopamine","volume":"137","author":"Crow","year":"1980","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.schres.2015.04.006_bb0020","first-page":"213","article-title":"WHO Studies of Schizophrenia: An Overview of the Results and Their Implications for an Understanding of the Disorder. Psychosocial Approaches to Deeply Disturbed Patients","author":"de Girolamo","year":"1996"},{"issue":"3","key":"10.1016\/j.schres.2015.04.006_bb0025","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/schbul\/22.3.545","article-title":"Identifying subtypes of schizophrenia by cluster analyses","volume":"22","author":"Dollfus","year":"1996","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.schres.2015.04.006_bb0030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0920-9964(02)00295-5","article-title":"A confirmatory factor analytic evaluation of the pentagonal PANSS model","volume":"61","author":"Fitzgerald","year":"2003","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.schres.2015.04.006_bb0035","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0924-9338(96)80298-7","article-title":"Epidemiology of schizophrenia. The disease model of schizophrenia in the light of current epidemiological knowledge","volume":"10","author":"H\u00e4fner","year":"1995","journal-title":"Eur. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2015.04.006_bb0040","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1097\/01.nmd.0000253783.32338.6e","article-title":"Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications: a 15-year multifollow-up study","volume":"195","author":"Harrow","year":"2007","journal-title":"J. Nerv. Ment. Dis."},{"issue":"5","key":"10.1016\/j.schres.2015.04.006_bb0045","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1046\/j.1440-1819.1998.00425.x","article-title":"Interrater reliability of the Japanese version of the Positive and Negative Syndrome Scale and the appraisal of its training effect","volume":"52","author":"Igarashi","year":"1998","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.schres.2015.04.006_bb0075","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/schbul\/16.3.537","article-title":"Pyramidical model of schizophrenia","volume":"16","author":"Kay","year":"1990","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.schres.2015.04.006_bb0050","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/schbul\/13.2.261","article-title":"The positive and negative syndrome scale (PANSS) for schizophrenia","volume":"13","author":"Kay","year":"1987","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.schres.2015.04.006_bb0060","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0165-1781(88)90038-8","article-title":"Reliability and validity of the positive and negative syndrome scale for schizophrenics","volume":"23","author":"Kay","year":"1988","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2015.04.006_bb0065","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1192\/S0007125000291514","article-title":"The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation","volume":"7","author":"Kay","year":"1989","journal-title":"Br. J. Psychiatry Suppl."},{"issue":"8","key":"10.1016\/j.schres.2015.04.006_bb0055","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1097\/00005053-199008000-00007","article-title":"The Positive and Negative Syndrome Scale\u2014Spanish adaptation","volume":"178","author":"Kay","year":"1990","journal-title":"J. Nerv. Ment. Dis."},{"issue":"4","key":"10.1016\/j.schres.2015.04.006_bb0070","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0010-440X(91)90085-Q","article-title":"SCID-PANSS: two-tier diagnostic system for psychotic disorders","volume":"32","author":"Kay","year":"1991","journal-title":"Compr. Psychiatry"},{"key":"10.1016\/j.schres.2015.04.006_bb0080","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/1471-244X-11-178","article-title":"Use of non-parametric item response theory to develop a shortened version of the Positive and Negative Syndrome Scale (PANSS)","volume":"11","author":"Khan","year":"2011","journal-title":"BMC Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2015.04.006_bb0085","doi-asserted-by":"crossref","first-page":"856","DOI":"10.4088\/JCP.11r07539","article-title":"Exploratory analyses of efficacy data from schizophrenia trials in support of new drug applications submitted to the US Food and Drug Administration","volume":"73","author":"Khin","year":"2012","journal-title":"J. Clin. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2015.04.006_bb0090","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1600-0447.1999.tb10851.x","article-title":"Validity and reliability of the French-language version of the Positive and Negative Syndrome Scale (PANSS)","volume":"100","author":"Lan\u00e7on","year":"1999","journal-title":"Acta Psychiatr. Scand."},{"issue":"5","key":"10.1016\/j.schres.2015.04.006_bb0095","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1192\/bjp.bp.109.075366","article-title":"Clinical relevance of findings in trials of antipsychotics: systematic review","volume":"198","author":"Lepping","year":"2011","journal-title":"Br. J. Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.schres.2015.04.006_bb0100","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","article-title":"What does the PANSS mean?","volume":"79","author":"Leucht","year":"2005","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.schres.2015.04.006_bb0105","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/schbul\/sbq016","article-title":"The PANSS should be rescaled","volume":"36","author":"Leucht","year":"2010","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.schres.2015.04.006_bb0110","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.psychres.2011.03.014","article-title":"Recommendations to improve the positive and negative syndrome scale (PANSS) based on item response theory","volume":"188","author":"Levine","year":"2011","journal-title":"Psychiatry Res."},{"issue":"4","key":"10.1016\/j.schres.2015.04.006_bb0115","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/BF02354306","article-title":"A new five factor model of schizophrenia","volume":"65","author":"Lindenmayer","year":"1994","journal-title":"Psychiatry Q."},{"issue":"3","key":"10.1016\/j.schres.2015.04.006_bb0120","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0920-9964(94)00041-6","article-title":"Five factor model of schizophrenia: replication across samples","volume":"14","author":"Lindenmayer","year":"1995","journal-title":"Schizophr. Res."},{"issue":"12","key":"10.1016\/j.schres.2015.04.006_bb0125","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4088\/JCP.v58n1205","article-title":"The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials","volume":"58","author":"Marder","year":"1997","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2015.04.006_bb0130","doi-asserted-by":"crossref","first-page":"s7","DOI":"10.1192\/bjp.191.50.s7","article-title":"Symptom rating scales and outcome in schizophrenia","volume":"50","author":"Mortimer","year":"2007","journal-title":"Br. J. Psychiatry Suppl."},{"issue":"3","key":"10.1016\/j.schres.2015.04.006_bb0135","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/schbul\/sbp124","article-title":"Should the PANSS be rescaled?","volume":"36","author":"Obermeier","year":"2010","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.schres.2015.04.006_bb0140","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1744-859X-12-32","article-title":"Definitions and drivers of relapse in patients with schizophrenia: a systematic literature review","volume":"12","author":"Olivares","year":"2013","journal-title":"Ann. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2015.04.006_bb0145","series-title":"Structured Clinical Interview for the PANSS (SCI-PANSS)","author":"Opler","year":"1992"},{"issue":"Suppl. 1","key":"10.1016\/j.schres.2015.04.006_bb0150","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0924-9338(11)71710-2","article-title":"Country differences in patient characteristics and treatment in schizophrenia: data from a physician-based survey in Europe","volume":"26","author":"Papageorgiou","year":"2011","journal-title":"Eur. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2015.04.006_bb0155","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0165-1781(94)90093-0","article-title":"Psychometric properties of the positive and negative syndrome scale (PANSS) in schizophrenia","volume":"53","author":"Peralta","year":"1994","journal-title":"Psychiatry Res."},{"issue":"5","key":"10.1016\/j.schres.2015.04.006_bb0160","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.pnpbp.2007.02.014","article-title":"Efficacy of flupentixol and risperidone in chronic schizophrenia with predominantly negative symptoms","volume":"31","author":"Ruhrmann","year":"2007","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.schres.2015.04.006_bb0165","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.schres.2005.09.002","article-title":"Factor structure and external validity of the PANSS revisited","volume":"82","author":"Van den Oord","year":"2006","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.schres.2015.04.006_bb0170","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.comppsych.2006.01.005","article-title":"Four symptom dimensions in outpatients with schizophrenia","volume":"47","author":"Villalta-Gil","year":"2006","journal-title":"Compr. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2015.04.006_bb0175","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1600-0447.1992.tb03298.x","article-title":"The Swedish version of the Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Construct validity and interrater reliability","volume":"86","author":"von Knorring","year":"1992","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.schres.2015.04.006_bb0180","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-0447.1995.tb05937.x","article-title":"Principal components and further possibilities with the PANSS","volume":"388","author":"von Knorring","year":"1995","journal-title":"Acta Psychiatr. Scand. Suppl."},{"issue":"1\u20133","key":"10.1016\/j.schres.2015.04.006_bb0185","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.schres.2012.01.031","article-title":"Searching for a consensus five-factor model of the Positive and Negative Syndrome Scale for schizophrenia","volume":"137","author":"Wallwork","year":"2012","journal-title":"Schizophr. Res."},{"issue":"5","key":"10.1016\/j.schres.2015.04.006_bb0190","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000285058","article-title":"Empirical assessment of the factorial structure of clinical symptoms in schizophrenia. A multisite, multimodel evaluation of the factorial structure of the Positive and Negative Syndrome Scale. The PANSS Study Group","volume":"30","author":"White","year":"1997","journal-title":"Psychopathology"}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996415001796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996415001796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T19:04:26Z","timestamp":1598987066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996415001796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":38,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0920996415001796"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2015.04.006","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"On the use of the Positive and Negative Syndrome Scale in randomized clinical trials","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2015.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}